Continue to site >
Trending ETFs

JPMorgan Small Cap Growth Fund

mutual fund
JGRQX
Payout Change
Suspended
Price as of:
$19.24 +0.08 +0.42%
primary theme
U.S. Small-Cap Growth Equity
JGRQX (Mutual Fund)

JPMorgan Small Cap Growth Fund

Payout Change
Suspended
Price as of:
$19.24 +0.08 +0.42%
primary theme
U.S. Small-Cap Growth Equity
JGRQX (Mutual Fund)

JPMorgan Small Cap Growth Fund

Payout Change
Suspended
Price as of:
$19.24 +0.08 +0.42%
primary theme
U.S. Small-Cap Growth Equity

Name

As of 11/29/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$19.24

$4.05 B

0.00%

1.29%

Vitals

YTD Return

21.7%

1 yr return

31.5%

3 Yr Avg Return

-1.6%

5 Yr Avg Return

7.3%

Net Assets

$4.05 B

Holdings in Top 10

15.7%

52 WEEK LOW AND HIGH

$19.2
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.29%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

$0

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 11/29/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$19.24

$4.05 B

0.00%

1.29%

JGRQX - Profile

Distributions

  • YTD Total Return 21.7%
  • 3 Yr Annualized Total Return -1.6%
  • 5 Yr Annualized Total Return 7.3%
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio -0.95%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    JPMorgan Small Cap Growth Fund
  • Fund Family Name
    JPMorgan Funds
  • Inception Date
    Aug 01, 2017
  • Shares Outstanding
    372496
  • Share Class
    R3
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Eytan Shapiro

Fund Description

Under normal circumstances, at least 80% of the Fund’s Assets will be invested in the securities of small capitalization companies. “Assets” means net assets, plus the amount of borrowings for investment purposes. Small cap companies are companies with market capitalizations equal to those within the universe of the Russell 2000® Growth Index stocks at the time of purchase. As of the reconstitution of the Russell 2000 Growth Index on September 30, 2024, the market capitalizations of the companies in the index ranged from $1.19 million to $13.51 billion. In implementing its main strategies, the Fund will invest primarily in common stocks. Typically, the Fund invests in securities of companies with a history of above-average growth, as well as companies expected to have above-average growth.Derivatives, which are instruments that have a value based on another instrument, exchange rate or index, may be used as substitutes for securities in which the Fund can invest. To the extent the Fund uses derivatives, the Fund will primarily use futures contracts to more effectively gain targeted equity exposure from its cash positions.Investment Process: In managing the Fund, the adviser employs a process that combines research, valuation and stock selection to identify companies that have a history of above-average growth or which the adviser believes will achieve above-average growth in the future. Growth companies purchased for the Fund include those with leading competitive positions that can achieve sustainable growth. As part of its investment process, the adviser seeks to assess the impact of environmental, social and governance (ESG) factors on many issuers in the universe in which the Fund may invest. The adviser’s assessment is based on an analysis of key opportunities and risks across industries to seek to identify financially material issues with respect to the Fund’s investments in securities and ascertain key issues that merit engagement with issuers. These assessments may not be conclusive and securities of issuers that may be negatively impacted by such factors may be purchased and retained by the Fund while the Fund may divest or not invest in securities of issuers that may be positively impacted by such factors.The adviser may sell a security for several reasons. A security may be sold due to a change in the company’s fundamentals or if the adviser believes the security is no longer attractively valued. Investments may also be sold if the adviser identifies a stock that it believes offers a better investment opportunity.
Read More

JGRQX - Performance

Return Ranking - Trailing

Period JGRQX Return Category Return Low Category Return High Rank in Category (%)
YTD 21.7% -0.2% 116.8% 53.87%
1 Yr 31.5% 6.0% 114.8% 73.99%
3 Yr -1.6%* -14.4% 64.7% 73.46%
5 Yr 7.3%* -2.5% 48.2% 83.76%
10 Yr N/A* 2.2% 25.4% 17.61%

* Annualized

Return Ranking - Calendar

Period JGRQX Return Category Return Low Category Return High Rank in Category (%)
2023 13.9% -20.5% 54.6% 54.81%
2022 -32.8% -82.1% 32.2% 67.10%
2021 -19.2% -90.6% 300.1% 82.45%
2020 48.0% -63.0% 127.9% 16.63%
2019 28.8% -7.7% 42.9% 21.53%

Total Return Ranking - Trailing

Period JGRQX Return Category Return Low Category Return High Rank in Category (%)
YTD 21.7% -0.2% 116.8% 53.87%
1 Yr 31.5% 6.0% 114.8% 73.99%
3 Yr -1.6%* -14.4% 64.7% 73.46%
5 Yr 7.3%* -2.5% 48.2% 83.76%
10 Yr N/A* 2.2% 25.4% 16.32%

* Annualized

Total Return Ranking - Calendar

Period JGRQX Return Category Return Low Category Return High Rank in Category (%)
2023 13.9% -19.0% 136.8% 69.07%
2022 -32.5% -59.9% 44.3% 77.94%
2021 -6.0% -22.7% 411.9% 96.04%
2020 59.2% 1.5% 150.8% 14.87%
2019 37.1% 5.5% 55.3% 13.48%

NAV & Total Return History


JGRQX - Holdings

Concentration Analysis

JGRQX Category Low Category High JGRQX % Rank
Net Assets 4.05 B 209 K 34.3 B 11.07%
Number of Holdings 132 7 1226 25.46%
Net Assets in Top 10 571 M 53.8 K 3.02 B 23.06%
Weighting of Top 10 15.68% 7.5% 100.0% 81.89%

Top 10 Holdings

  1. Applied Industrial Technologies, Inc. 1.93%
  2. Vaxcyte, Inc. 1.78%
  3. FTAI Aviation Ltd. 1.78%
  4. Halozyme Therapeutics, Inc. 1.69%
  5. Cactus, Inc., Class A 1.50%
  6. Casella Waste Systems, Inc., Class A 1.49%
  7. AAON, Inc. 1.47%
  8. Insmed, Inc. 1.36%
  9. Verra Mobility Corp. 1.36%
  10. REVOLUTION Medicines, Inc. 1.32%

Asset Allocation

Weighting Return Low Return High JGRQX % Rank
Stocks
99.42% 92.05% 107.62% 19.74%
Cash
1.80% 0.00% 28.78% 54.43%
Preferred Stocks
0.00% 0.00% 4.59% 83.76%
Other
0.00% -0.26% 6.70% 85.79%
Convertible Bonds
0.00% 0.00% 1.57% 82.66%
Bonds
0.00% 0.00% 2.40% 82.47%

Stock Sector Breakdown

Weighting Return Low Return High JGRQX % Rank
Healthcare
25.68% 0.00% 47.90% 25.28%
Technology
25.46% 2.91% 75.51% 50.37%
Industrials
18.32% 0.00% 36.64% 36.35%
Consumer Cyclical
14.84% 0.00% 24.04% 26.01%
Consumer Defense
6.05% 0.00% 13.56% 17.34%
Financial Services
4.02% 0.00% 42.95% 82.10%
Energy
2.46% 0.00% 55.49% 53.51%
Real Estate
2.25% 0.00% 15.31% 47.05%
Communication Services
0.63% 0.00% 15.31% 76.75%
Utilities
0.25% 0.00% 5.57% 30.07%
Basic Materials
0.03% 0.00% 9.24% 83.95%

Stock Geographic Breakdown

Weighting Return Low Return High JGRQX % Rank
US
99.42% 17.30% 107.62% 15.68%
Non US
0.00% 0.00% 77.12% 85.24%

JGRQX - Expenses

Operational Fees

JGRQX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.29% 0.05% 23.20% 41.59%
Management Fee 0.65% 0.05% 1.62% 21.44%
12b-1 Fee 0.25% 0.00% 1.00% 61.02%
Administrative Fee 0.08% 0.01% 0.40% 44.56%

Sales Fees

JGRQX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

JGRQX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

JGRQX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 3.00% 264.00% 43.38%

JGRQX - Distributions

Dividend Yield Analysis

JGRQX Category Low Category High JGRQX % Rank
Dividend Yield 0.00% 0.00% 6.91% 86.16%

Dividend Distribution Analysis

JGRQX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annual SemiAnnual Annual

Net Income Ratio Analysis

JGRQX Category Low Category High JGRQX % Rank
Net Income Ratio -0.95% -2.47% 1.10% 70.15%

Capital Gain Distribution Analysis

JGRQX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Monthly Annually

Distributions History

View More +

JGRQX - Fund Manager Analysis

Managers

Eytan Shapiro


Start Date

Tenure

Tenure Rank

Sep 01, 2004

17.76

17.8%

Eytan Shapiro, managing director, is the CIO of the Growth &Small Cap U.S. Equity Team. Mr. Shapiro has worked as a portfolio manager for JPMIM or its affiliates (or their predecessors) since 1989 and has been employed by the firm since 1985. Eytan holds a B.Sc. in economics from City University, London, an M.Phil. in economics from Oxford University, and is Series 66 licensed. He is a member of both the New York Society of Security Analysts and The CFA Institute, and a CFA charterholder. He began his investment career in 1982.

Matthew Cohen


Start Date

Tenure

Tenure Rank

Nov 01, 2016

5.58

5.6%

Matthew G. Cohen, M.D., managing director, is a research analyst in the U.S. Equity Group. An employee since 2005, Dr. Cohen has been portfolio manager since 2015 and a research analyst in the firm’s U.S. Equity Group since 2005. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund. Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital NYU School of Medicine. Matthew holds an M.B.A. from New York University Stern School of Business and an M.D. from McGill University in Montreal.

Felise Agranoff


Start Date

Tenure

Tenure Rank

Nov 01, 2016

5.58

5.6%

Felise L. Agranoff, managing director, is a portfolio manager and research analyst within the U.S. Equity Group. An employee since 2004, Felise is a co-portfolio manager of the Mid Cap Growth, Growth Advantage and Small Cap Growth Strategies. Additionally, she has research responsibility for the small and mid cap industrial sector as well as mid cap financials and business services. Prior to joining the growth team as a research analyst in 2006, Felise previously worked on the J.P. Morgan U.S. Equity Large Cap fundamental research team. Felise obtained a B.S. in Finance and Accounting from the McIntire School of Commerce at the University of Virginia. She is a member of the CFA Institute and a CFA charterholder.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.08 30.44 9.15 5.25